VUR is one of the most common congenital urological diseases causing Hydronephrosis in children, resulting in significant morbidity ranging from recurrent UTIs to Renal scarring. In this study we will evaluate the efficacy of Deflux Injection in treating various grades of VUR, its cost effectiveness and its different techniques. This is a prospective, cross-sectional study. Patient with Primary VUR, Grade I, Grade II, Grade III VUR, and patient with American Society of Anesthesiologists (ASA) i, ii were included in the study. Statistical package of social sciences (SPSS) version 23 was used to enter, sort, and analyze the data. Descriptive characteristics included age, gender, weight, and height were analyzed in mean ± standard deviation. Independent variables were analyzed with frequency. Post-operative complication, success rates were analyzed as end point of study. The gender distribution of participants was 5 (23.8%) males and 16 (76.1%) females with mean weight measuring as 17.5 ± 8.3Kgs. Post-operative ultrasonography results indicated 100% resolution in Grade I and II VUR, while 75% resolution in Grade III VUR, 50% resolution in Grade IV VUR, whereas 25% resolution in Grade V VUR. Our study shows that endoscopic injection of Dextranomer/Hyaluronic acid copolymer in treating VUR has overall good and comparable success rates in grade I to grade iv VUR with open surgery. For grade V VURs, patients and parents can be counseled that this procedure has a 60% success rate and due to its minimal invasiveness can be undertaken with no extra added risks if further laparoscopic or open surgery is required later on.